Ontology highlight
ABSTRACT: Background
Pharmacogenomic factors affect the susceptibility to drug-drug interactions (DDI). We identified drug interaction perpetrators among the drugs prescribed to a cohort of 290 older adults and analysed the prevalence of gene polymorphisms that can increase their interacting potential. We also pinpointed clinical decision support systems (CDSSs) that incorporate pharmacogenomic factors in DDI risk evaluation.Methods
Perpetrator drugs were identified using the Drug Interactions Flockhart Table, the DRUGBANK website, and the Mayo Clinic Pharmacogenomics Association Table. Allelic variants affecting their activity were identified with the PharmVar, PharmGKB, dbSNP, ensembl and 1000 genome databases.Results
Amiodarone, amlodipine, atorvastatin, digoxin, esomperaz
SUBMITTER: Cataldi M
PROVIDER: S-EPMC10514861 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature